STATEMENTS OF CASH FLOWS - USD ($) | 12 Months Ended |
Mar. 31, 2023 | Mar. 31, 2022 |
Cash flows from operating activities | | |
Net income (loss) for financial reporting purposes | $ 3,354,800 | $ 2,545,668 |
Adjustments to reconcile net income (loss) to net cash used in operating activities | | |
Gain on sale of operating limited partnerships | (3,596,277) | (3,551,414) |
Changes in assets and liabilities | | |
Other assets | 377 | 4,541 |
Accounts payable, accrued expenses and other liabilities | 1 | (27) |
Accounts payable - affiliates | (1,746,384) | (2,632,811) |
Net cash used in operating activities | (1,987,483) | (3,634,043) |
Cash flows from investing activities | | |
Proceeds from disposition of operating limited partnerships | 3,596,277 | 3,551,414 |
Net cash provided by investing activities | 3,596,277 | 3,551,414 |
Cash flows from financing activities | | |
Distributions | (3,471,447) | (8,366,058) |
Net cash used in financing activities | (3,471,447) | (8,366,058) |
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | (1,862,653) | (8,448,687) |
Cash and cash equivalents, beginning | 2,370,898 | 10,819,585 |
Cash and cash equivalents, ending | 508,245 | 2,370,898 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 1,249,375 |
Series 20 | | |
Cash flows from operating activities | | |
Net income (loss) for financial reporting purposes | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash used in operating activities | | |
Gain on sale of operating limited partnerships | 0 | 0 |
Changes in assets and liabilities | | |
Other assets | 0 | 0 |
Accounts payable, accrued expenses and other liabilities | 0 | 0 |
Accounts payable - affiliates | 0 | 0 |
Net cash used in operating activities | 0 | 0 |
Cash flows from investing activities | | |
Proceeds from disposition of operating limited partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 21 | | |
Cash flows from operating activities | | |
Net income (loss) for financial reporting purposes | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash used in operating activities | | |
Gain on sale of operating limited partnerships | 0 | 0 |
Changes in assets and liabilities | | |
Other assets | 0 | 0 |
Accounts payable, accrued expenses and other liabilities | 0 | 0 |
Accounts payable - affiliates | 0 | 0 |
Net cash used in operating activities | 0 | 0 |
Cash flows from investing activities | | |
Proceeds from disposition of operating limited partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 22 | | |
Cash flows from operating activities | | |
Net income (loss) for financial reporting purposes | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash used in operating activities | | |
Gain on sale of operating limited partnerships | 0 | 0 |
Changes in assets and liabilities | | |
Other assets | 0 | 0 |
Accounts payable, accrued expenses and other liabilities | 0 | 0 |
Accounts payable - affiliates | 0 | 0 |
Net cash used in operating activities | 0 | 0 |
Cash flows from investing activities | | |
Proceeds from disposition of operating limited partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 23 | | |
Cash flows from operating activities | | |
Net income (loss) for financial reporting purposes | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash used in operating activities | | |
Gain on sale of operating limited partnerships | 0 | 0 |
Changes in assets and liabilities | | |
Other assets | 0 | 0 |
Accounts payable, accrued expenses and other liabilities | 0 | 0 |
Accounts payable - affiliates | 0 | 0 |
Net cash used in operating activities | 0 | 0 |
Cash flows from investing activities | | |
Proceeds from disposition of operating limited partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 24 | | |
Cash flows from operating activities | | |
Net income (loss) for financial reporting purposes | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash used in operating activities | | |
Gain on sale of operating limited partnerships | 0 | 0 |
Changes in assets and liabilities | | |
Other assets | 0 | 0 |
Accounts payable, accrued expenses and other liabilities | 0 | 0 |
Accounts payable - affiliates | 0 | 0 |
Net cash used in operating activities | 0 | 0 |
Cash flows from investing activities | | |
Proceeds from disposition of operating limited partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 25 | | |
Cash flows from operating activities | | |
Net income (loss) for financial reporting purposes | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash used in operating activities | | |
Gain on sale of operating limited partnerships | 0 | 0 |
Changes in assets and liabilities | | |
Other assets | 0 | 0 |
Accounts payable, accrued expenses and other liabilities | 0 | 0 |
Accounts payable - affiliates | 0 | 0 |
Net cash used in operating activities | 0 | 0 |
Cash flows from investing activities | | |
Proceeds from disposition of operating limited partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 26 | | |
Cash flows from operating activities | | |
Net income (loss) for financial reporting purposes | 0 | (91,580) |
Adjustments to reconcile net income (loss) to net cash used in operating activities | | |
Gain on sale of operating limited partnerships | 0 | (20,845) |
Changes in assets and liabilities | | |
Other assets | 0 | 75 |
Accounts payable, accrued expenses and other liabilities | 0 | 0 |
Accounts payable - affiliates | 0 | (2,199) |
Net cash used in operating activities | 0 | (114,549) |
Cash flows from investing activities | | |
Proceeds from disposition of operating limited partnerships | 0 | 20,845 |
Net cash provided by investing activities | 0 | 20,845 |
Cash flows from financing activities | | |
Distributions | 0 | (437,323) |
Net cash used in financing activities | 0 | (437,323) |
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | (531,027) |
Cash and cash equivalents, beginning | 0 | 531,027 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 27 | | |
Cash flows from operating activities | | |
Net income (loss) for financial reporting purposes | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash used in operating activities | | |
Gain on sale of operating limited partnerships | 0 | 0 |
Changes in assets and liabilities | | |
Other assets | 0 | 0 |
Accounts payable, accrued expenses and other liabilities | 0 | 0 |
Accounts payable - affiliates | 0 | 0 |
Net cash used in operating activities | 0 | 0 |
Cash flows from investing activities | | |
Proceeds from disposition of operating limited partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 28 | | |
Cash flows from operating activities | | |
Net income (loss) for financial reporting purposes | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash used in operating activities | | |
Gain on sale of operating limited partnerships | 0 | 0 |
Changes in assets and liabilities | | |
Other assets | 0 | 0 |
Accounts payable, accrued expenses and other liabilities | 0 | 0 |
Accounts payable - affiliates | 0 | 0 |
Net cash used in operating activities | 0 | 0 |
Cash flows from investing activities | | |
Proceeds from disposition of operating limited partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 29 | | |
Cash flows from operating activities | | |
Net income (loss) for financial reporting purposes | (66,052) | (36,279) |
Adjustments to reconcile net income (loss) to net cash used in operating activities | | |
Gain on sale of operating limited partnerships | 0 | (29,999) |
Changes in assets and liabilities | | |
Other assets | (82) | (352) |
Accounts payable, accrued expenses and other liabilities | 0 | 0 |
Accounts payable - affiliates | 4,512 | (18,837) |
Net cash used in operating activities | (61,622) | (85,467) |
Cash flows from investing activities | | |
Proceeds from disposition of operating limited partnerships | 0 | 29,999 |
Net cash provided by investing activities | 0 | 29,999 |
Cash flows from financing activities | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | (61,622) | (55,468) |
Cash and cash equivalents, beginning | 108,768 | 164,236 |
Cash and cash equivalents, ending | 47,146 | 108,768 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 30 | | |
Cash flows from operating activities | | |
Net income (loss) for financial reporting purposes | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash used in operating activities | | |
Gain on sale of operating limited partnerships | 0 | 0 |
Changes in assets and liabilities | | |
Other assets | 0 | 0 |
Accounts payable, accrued expenses and other liabilities | 0 | 0 |
Accounts payable - affiliates | 0 | 0 |
Net cash used in operating activities | 0 | 0 |
Cash flows from investing activities | | |
Proceeds from disposition of operating limited partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 31 | | |
Cash flows from operating activities | | |
Net income (loss) for financial reporting purposes | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash used in operating activities | | |
Gain on sale of operating limited partnerships | 0 | 0 |
Changes in assets and liabilities | | |
Other assets | 0 | 0 |
Accounts payable, accrued expenses and other liabilities | 0 | 0 |
Accounts payable - affiliates | 0 | 0 |
Net cash used in operating activities | 0 | 0 |
Cash flows from investing activities | | |
Proceeds from disposition of operating limited partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 32 | | |
Cash flows from operating activities | | |
Net income (loss) for financial reporting purposes | 0 | (81,264) |
Adjustments to reconcile net income (loss) to net cash used in operating activities | | |
Gain on sale of operating limited partnerships | 0 | (23,823) |
Changes in assets and liabilities | | |
Other assets | 0 | 74 |
Accounts payable, accrued expenses and other liabilities | 0 | 0 |
Accounts payable - affiliates | 0 | (4,847) |
Net cash used in operating activities | 0 | (109,860) |
Cash flows from investing activities | | |
Proceeds from disposition of operating limited partnerships | 0 | 23,823 |
Net cash provided by investing activities | 0 | 23,823 |
Cash flows from financing activities | | |
Distributions | 0 | (2,554,377) |
Net cash used in financing activities | 0 | (2,554,377) |
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | (2,640,414) |
Cash and cash equivalents, beginning | 0 | 2,640,414 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 33 | | |
Cash flows from operating activities | | |
Net income (loss) for financial reporting purposes | 0 | (87,109) |
Adjustments to reconcile net income (loss) to net cash used in operating activities | | |
Gain on sale of operating limited partnerships | 0 | (23,823) |
Changes in assets and liabilities | | |
Other assets | 0 | 74 |
Accounts payable, accrued expenses and other liabilities | 0 | 0 |
Accounts payable - affiliates | 0 | (4,992) |
Net cash used in operating activities | 0 | (115,850) |
Cash flows from investing activities | | |
Proceeds from disposition of operating limited partnerships | 0 | 23,823 |
Net cash provided by investing activities | 0 | 23,823 |
Cash flows from financing activities | | |
Distributions | 0 | (2,948,609) |
Net cash used in financing activities | 0 | (2,948,609) |
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | (3,040,636) |
Cash and cash equivalents, beginning | 0 | 3,040,636 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 34 | | |
Cash flows from operating activities | | |
Net income (loss) for financial reporting purposes | (68,224) | (65,928) |
Adjustments to reconcile net income (loss) to net cash used in operating activities | | |
Gain on sale of operating limited partnerships | 0 | 0 |
Changes in assets and liabilities | | |
Other assets | (82) | 74 |
Accounts payable, accrued expenses and other liabilities | 0 | 0 |
Accounts payable - affiliates | 18,492 | 18,492 |
Net cash used in operating activities | (49,814) | (47,362) |
Cash flows from investing activities | | |
Proceeds from disposition of operating limited partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | (49,814) | (47,362) |
Cash and cash equivalents, beginning | 81,705 | 129,067 |
Cash and cash equivalents, ending | 31,891 | 81,705 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 35 | | |
Cash flows from operating activities | | |
Net income (loss) for financial reporting purposes | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash used in operating activities | | |
Gain on sale of operating limited partnerships | 0 | 0 |
Changes in assets and liabilities | | |
Other assets | 0 | 0 |
Accounts payable, accrued expenses and other liabilities | 0 | 0 |
Accounts payable - affiliates | 0 | 0 |
Net cash used in operating activities | 0 | 0 |
Cash flows from investing activities | | |
Proceeds from disposition of operating limited partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 36 | | |
Cash flows from operating activities | | |
Net income (loss) for financial reporting purposes | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash used in operating activities | | |
Gain on sale of operating limited partnerships | 0 | 0 |
Changes in assets and liabilities | | |
Other assets | 0 | 0 |
Accounts payable, accrued expenses and other liabilities | 0 | 0 |
Accounts payable - affiliates | 0 | 0 |
Net cash used in operating activities | 0 | 0 |
Cash flows from investing activities | | |
Proceeds from disposition of operating limited partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 37 | | |
Cash flows from operating activities | | |
Net income (loss) for financial reporting purposes | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash used in operating activities | | |
Gain on sale of operating limited partnerships | 0 | 0 |
Changes in assets and liabilities | | |
Other assets | 0 | 0 |
Accounts payable, accrued expenses and other liabilities | 0 | 0 |
Accounts payable - affiliates | 0 | 0 |
Net cash used in operating activities | 0 | 0 |
Cash flows from investing activities | | |
Proceeds from disposition of operating limited partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 38 | | |
Cash flows from operating activities | | |
Net income (loss) for financial reporting purposes | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash used in operating activities | | |
Gain on sale of operating limited partnerships | 0 | 0 |
Changes in assets and liabilities | | |
Other assets | 0 | 0 |
Accounts payable, accrued expenses and other liabilities | 0 | 0 |
Accounts payable - affiliates | 0 | 0 |
Net cash used in operating activities | 0 | 0 |
Cash flows from investing activities | | |
Proceeds from disposition of operating limited partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 39 | | |
Cash flows from operating activities | | |
Net income (loss) for financial reporting purposes | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash used in operating activities | | |
Gain on sale of operating limited partnerships | 0 | 0 |
Changes in assets and liabilities | | |
Other assets | 0 | 0 |
Accounts payable, accrued expenses and other liabilities | 0 | 0 |
Accounts payable - affiliates | 0 | 0 |
Net cash used in operating activities | 0 | 0 |
Cash flows from investing activities | | |
Proceeds from disposition of operating limited partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 40 | | |
Cash flows from operating activities | | |
Net income (loss) for financial reporting purposes | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash used in operating activities | | |
Gain on sale of operating limited partnerships | 0 | 0 |
Changes in assets and liabilities | | |
Other assets | 0 | 0 |
Accounts payable, accrued expenses and other liabilities | 0 | 0 |
Accounts payable - affiliates | 0 | 0 |
Net cash used in operating activities | 0 | 0 |
Cash flows from investing activities | | |
Proceeds from disposition of operating limited partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 41 | | |
Cash flows from operating activities | | |
Net income (loss) for financial reporting purposes | 0 | 1,032,291 |
Adjustments to reconcile net income (loss) to net cash used in operating activities | | |
Gain on sale of operating limited partnerships | 0 | (1,151,653) |
Changes in assets and liabilities | | |
Other assets | 0 | 437 |
Accounts payable, accrued expenses and other liabilities | 0 | (1) |
Accounts payable - affiliates | 0 | (1,441,470) |
Net cash used in operating activities | 0 | (1,560,396) |
Cash flows from investing activities | | |
Proceeds from disposition of operating limited partnerships | 0 | 1,151,653 |
Net cash provided by investing activities | 0 | 1,151,653 |
Cash flows from financing activities | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | (408,743) |
Cash and cash equivalents, beginning | 0 | 408,743 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 1,249,375 |
Series 42 | | |
Cash flows from operating activities | | |
Net income (loss) for financial reporting purposes | 0 | 143,547 |
Adjustments to reconcile net income (loss) to net cash used in operating activities | | |
Gain on sale of operating limited partnerships | 0 | (247,877) |
Changes in assets and liabilities | | |
Other assets | 0 | 82 |
Accounts payable, accrued expenses and other liabilities | 0 | 0 |
Accounts payable - affiliates | 0 | (36,736) |
Net cash used in operating activities | 0 | (140,984) |
Cash flows from investing activities | | |
Proceeds from disposition of operating limited partnerships | 0 | 247,877 |
Net cash provided by investing activities | 0 | 247,877 |
Cash flows from financing activities | | |
Distributions | 0 | (2,425,749) |
Net cash used in financing activities | 0 | (2,425,749) |
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | (2,318,856) |
Cash and cash equivalents, beginning | 0 | 2,318,856 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 43 | | |
Cash flows from operating activities | | |
Net income (loss) for financial reporting purposes | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash used in operating activities | | |
Gain on sale of operating limited partnerships | 0 | 0 |
Changes in assets and liabilities | | |
Other assets | 0 | 0 |
Accounts payable, accrued expenses and other liabilities | 0 | 0 |
Accounts payable - affiliates | 0 | 0 |
Net cash used in operating activities | 0 | 0 |
Cash flows from investing activities | | |
Proceeds from disposition of operating limited partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 44 | | |
Cash flows from operating activities | | |
Net income (loss) for financial reporting purposes | 1,755,220 | 758,807 |
Adjustments to reconcile net income (loss) to net cash used in operating activities | | |
Gain on sale of operating limited partnerships | (1,746,178) | (815,747) |
Changes in assets and liabilities | | |
Other assets | 0 | 205 |
Accounts payable, accrued expenses and other liabilities | 0 | (26) |
Accounts payable - affiliates | (28,269) | (371,220) |
Net cash used in operating activities | (19,227) | (427,981) |
Cash flows from investing activities | | |
Proceeds from disposition of operating limited partnerships | 1,746,178 | 815,747 |
Net cash provided by investing activities | 1,746,178 | 815,747 |
Cash flows from financing activities | | |
Distributions | (2,957,455) | 0 |
Net cash used in financing activities | (2,957,455) | 0 |
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | (1,230,504) | 387,766 |
Cash and cash equivalents, beginning | 1,230,504 | 842,738 |
Cash and cash equivalents, ending | 0 | 1,230,504 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 45 | | |
Cash flows from operating activities | | |
Net income (loss) for financial reporting purposes | 1,364,970 | 596,405 |
Adjustments to reconcile net income (loss) to net cash used in operating activities | | |
Gain on sale of operating limited partnerships | (1,411,858) | (691,381) |
Changes in assets and liabilities | | |
Other assets | 0 | 2,627 |
Accounts payable, accrued expenses and other liabilities | 0 | 0 |
Accounts payable - affiliates | (1,138,508) | (606,165) |
Net cash used in operating activities | (1,185,396) | (698,514) |
Cash flows from investing activities | | |
Proceeds from disposition of operating limited partnerships | 1,411,858 | 691,381 |
Net cash provided by investing activities | 1,411,858 | 691,381 |
Cash flows from financing activities | | |
Distributions | (513,992) | 0 |
Net cash used in financing activities | (513,992) | 0 |
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | (287,530) | (7,133) |
Cash and cash equivalents, beginning | 287,530 | 294,663 |
Cash and cash equivalents, ending | 0 | 287,530 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 46 | | |
Cash flows from operating activities | | |
Net income (loss) for financial reporting purposes | 368,886 | 376,778 |
Adjustments to reconcile net income (loss) to net cash used in operating activities | | |
Gain on sale of operating limited partnerships | (438,241) | (546,266) |
Changes in assets and liabilities | | |
Other assets | 541 | 1,245 |
Accounts payable, accrued expenses and other liabilities | 1 | 0 |
Accounts payable - affiliates | (602,611) | (164,837) |
Net cash used in operating activities | (671,424) | (333,080) |
Cash flows from investing activities | | |
Proceeds from disposition of operating limited partnerships | 438,241 | 546,266 |
Net cash provided by investing activities | 438,241 | 546,266 |
Cash flows from financing activities | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | (233,183) | 213,186 |
Cash and cash equivalents, beginning | 662,391 | 449,205 |
Cash and cash equivalents, ending | 429,208 | 662,391 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | $ 0 | $ 0 |